Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Snelling

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|December 29, 2012
Q Fever with transient antiphospholipid antibodies associated with cholecystitis and splenic infarctionJames P Newcombe, Paul E A Gray, Pam Palasanthiran, et al.
Pediatrics|February 12, 2014
Duration of protection after first dose of acellular pertussis vaccine in infantsHelen E Quinn, Thomas L Snelling, Kristine K Macartney, et al.
Journal of Paediatrics and Child Health|November 19, 2016
Paediatrician beliefs and practices around influenza vaccinationJames P Newcombe, Rajneesh Kaur, Nicholas Wood, et al.
Contemporary Clinical Trials Communications|December 5, 2019
Choosing primary endpoints for clinical trials of health care interventionsCharlie McLeod, Richard Norman, Edward Litton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 13, 2026
A Pragmatic Bayesian Adaptive Trial Design Based on the Value of Information: The Value-Driven Adaptive DesignMichael Dymock, Julie A Marsh, Mark Jones, et al.
Trials|August 27, 2020
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis planMark A Jones, Todd Graves, Bianca Middleton, et al.
Vaccine|December 18, 2022
Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021Bianca F Middleton, Margie Danchin, Parveen Fathima, et al.
Pediatrics|September 17, 2014
Parental Tdap boosters and infant pertussis: a case-control studyHelen E Quinn, Thomas L Snelling, Andrew Habig, et al.
Expert Review of Vaccines|August 6, 2014
Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiologySarah L Sheridan, Katie Frith, Thomas L Snelling, et al.
Emerging Microbes & Infections|June 4, 2015
Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine eraCeleste M Donato, Daniel Cowley, Thomas L Snelling, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|December 29, 2012
Q Fever with transient antiphospholipid antibodies associated with cholecystitis and splenic infarctionJames P Newcombe, Paul E A Gray, Pam Palasanthiran, et al.
Pediatrics|February 12, 2014
Duration of protection after first dose of acellular pertussis vaccine in infantsHelen E Quinn, Thomas L Snelling, Kristine K Macartney, et al.
Journal of Paediatrics and Child Health|November 19, 2016
Paediatrician beliefs and practices around influenza vaccinationJames P Newcombe, Rajneesh Kaur, Nicholas Wood, et al.
Contemporary Clinical Trials Communications|December 5, 2019
Choosing primary endpoints for clinical trials of health care interventionsCharlie McLeod, Richard Norman, Edward Litton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 13, 2026
A Pragmatic Bayesian Adaptive Trial Design Based on the Value of Information: The Value-Driven Adaptive DesignMichael Dymock, Julie A Marsh, Mark Jones, et al.
Trials|August 27, 2020
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis planMark A Jones, Todd Graves, Bianca Middleton, et al.
Vaccine|December 18, 2022
Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021Bianca F Middleton, Margie Danchin, Parveen Fathima, et al.
Pediatrics|September 17, 2014
Parental Tdap boosters and infant pertussis: a case-control studyHelen E Quinn, Thomas L Snelling, Andrew Habig, et al.
Expert Review of Vaccines|August 6, 2014
Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiologySarah L Sheridan, Katie Frith, Thomas L Snelling, et al.
Emerging Microbes & Infections|June 4, 2015
Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine eraCeleste M Donato, Daniel Cowley, Thomas L Snelling, et al.
Pageof 8